Indian registered clinical trials soar

By Nick Taylor

- Last updated on GMT

Related tags: Clinical trials, Clinical trial, India

Clinical trials registered in India have soared in the past 12 months, as the nation has shifted its policy on recording full study details from voluntary to advisory and in June to mandatory.

By changing the policy Indian regulators hoped to increase transparency and bring the country’s procedures inline with other agencies. At the start of 2009 the drugs controller general of India (DCGI) advised that companies should register clinical trials in India.

This move had a small but noticeable effect on clinical trial registrations, which are detailed on the graph below. However, since news that registration would become mandatory surfaced in April the number of clinical trials posted has increased significantly.

indian graph

In August 76 clinical trials were registered, a new high for India but still considerably fewer than in the US, where clinicaltrials.gov records 520 studies being added over the same period.

However, India is predicted to capture a larger share of the clinical trial market in coming years and mandatory registration forms part of this effort.

By registering all human trials it is hoped that the nation will improve its reputation as a place to conduct clinical trials, encouraging wary companies to operate in the country.

Furthermore, India is trying to avoid a repeat of the problems that led to 49 infants dying during clinical trials. This caused a political backlash against foreign companies conducting clinical trials in India.

The data was collected on 31st August from the Clinical Trial Registry – India​, which contains information about a study’s purpose, sponsors and principal investigator. At the time of collection 454 trials were registered on the website.

Related news

Show more

Related products

show more

CellCarta - Mapping Precision Medicine

CellCarta - Mapping Precision Medicine

CellCarta | 17-Jan-2022 | Product Presentation

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

What to consider when working with CRFs

What to consider when working with CRFs

Formedix | 01-Nov-2021 | Technical / White Paper

For a study to be successful, data collected must be correct and complete. To be correct and complete, forms must be well planned with meticulous attention...

Automating clinical trials for success

Automating clinical trials for success

Formedix | 06-Oct-2021 | Technical / White Paper

This article gives gives a brief overview of why automation is absolutely essential for clinical trial success.

Related suppliers

Follow us

Products

View more

Webinars